immunoglobulin ͉ innate immunity ͉ phylogeny
T
he Fc receptors for IgG have been intensively characterized in mammals. They provide an important link between the acquired humoral immune response and innate cellular effector responses. Binding of immune complexes initiate effector functions such as phagocytosis, antibody-dependent cellular cytotoxicity, degranulation of mast cells or neutrophils, and release of cytokines and cytotoxic mediators (1) . The Fc receptors for IgG are clustered on chromosome 1 in humans. This chromosomal region also encodes FcRI␣, FcRI␥, and eight Fc receptor-like genes of unknown functions (2) .
In mammals, four different Fc receptors for IgG have been identified, which bind IgG or immune complexes with high (Fc␥RI), intermediate (Fc␥RIV) , or low affinity (Fc␥RII and Fc␥RIII), and they are further classified by their preferential binding to different isotypes (3) . Functionally, Fc receptors are divided into activating and inhibitory receptors. Activating receptors, except for human Fc␥RIIA, associate with FcRI␥ that has a cytoplasmic immunoreceptor tyrosine-based activation motif. The inhibitory Fc␥RII〉 is a monomeric molecule that displays a single immunoreceptor tyrosine-based inhibition motif (ITIM) in its cytoplasmic domain (4) .
The cellular distribution of the Fc receptors varies, but it is limited mainly to cells of the innate immune system such as mast cells, granulocytes, and macrophages. Fc␥RIIB is the only Fc receptor expressed on B cells, apart from some Fc receptor-like proteins. It controls BCR-mediated signals and can inhibit B cell activation and proliferation, thereby maintaining peripheral tolerance. On macrophages, mast cells, and neutrophils Fc␥RIIB is expressed together with activating Fc receptors (3) . This simultaneous triggering of activating and inhibitory Fc receptors has served as a paradigm for a growing number of immune receptor families, where antagonizing receptor pairs are coexpressed on the same cell. In these instances it is envisioned that a certain threshold has to be reached to trigger activation of a cell (5) .
Ig and various cell types of the innate immune system have been conserved in jawed vertebrates, indicating that Fc receptors should be present in nonmammalian vertebrates, too. In the chicken, the three Ig isotypes (IgM, IgA, and IgY) have been described. IgY displays functional properties of IgG, but contains four C H domains and thus has been classified as a homologue to either mammalian IgG or IgE (6) . However, there is only scarce information regarding nonmammalian Fc receptors. A soluble Fc receptor homolog that binds to IgM has recently been described in the catfish (7) . In an attempt to identify a chicken equivalent of the mammalian MHCrelated neonatal Fc receptor, a homologue of the secretory phospholipase A2 receptor that is expressed in the yolk sac has been identified. Despite its different structure, this receptor mediates the pH-dependent transfer of IgY from the yolk to the embryo similar to the function of the neonatal Fc receptor (8) . Recently, a chicken Fc receptor-like gene has been cloned, without further functional characterization (9) . In addition, a chicken poly Ig receptor that binds to chicken IgA has been identified that contains only four instead of five Ig domains (10) . Classical Fc receptors for IgG or IgA that connect innate and adaptive immune responses are currently unknown in the chicken or other nonmammalian vertebrates.
In addition to the Fc receptors that cluster on human chromosome 1, the human Fc␣RI (CD89) is localized on chromosome 19 in the leukocyte receptor complex (LRC). The LRC encodes various gene families such as killer cell Ig-like receptors and leukocyte Ig-like receptors (LILR) that contain multiple activating and inhibitory receptor pairs (11) . CD89 shares more homology to the LILR than to other Fc receptors. Moreover, the binding to IgA markedly differ from the Fc␥-Ig interaction. The N-terminal domain of CD89 interacts with the C␣2 and C␣3 domains of IgA, whereas in Fc␥Rs and FcR binding to the Fc region is mediated by the membrane proximal domain (12) . The Fc␣RI has other unique features such as the independence from FcRI␥ for surface expression and the bifunctional nature of Fc␣RI, dependent on the binding of soluble IgA versus IgA complexes (13) .
The corresponding chicken LRC on microchromosome 31 is vastly expanded with Ͼ60 functional chicken Ig-like receptor (CHIR) genes (14, 15) . The entire microchromosome may thus be occupied with members of the chicken LRC. In addition to the large number of genes, the family is further diversified by variations in gene content and allelic polymorphism (15) . All CHIRs are composed of one or two Ig domains and are further categorized in activating, inhibitory, and bifunctional receptors based on the presence or absence of a basic transmembrane residue and cytoplasmic ITIM (15, 16 
Results

CHIR-AB1 Binds the Fc Region of IgY (FcY).
To characterize ligands specific for CHIR we adapted the BWZ.36 reporter assay used previously to identify NKR-P1 ligands (17) . Chimeric constructs with N-terminal FLAG-tagged CHIR Ig domains, the chicken CD8␣ transmembrane domain, and the mouse CD3 cytoplasmic domain were generated from different subgroups of CHIR. BWZ.36 cells were stably transfected with these constructs and functionally tested for ␤-galactosidase activity by cross-linking with an anti-FLAG mAb. All cell lines strongly reacted with the anti-FLAG mAb (Fig. 1a) as compared with mock-transfected controls (data not shown). A variety of different chicken cell lines, primary cells, and plate-immobilized soluble molecules were successively used for screening to identify potential ligands. Plate-bound IgY, but not IgA or IgM elicited a strong signal in BWZ.36-CHIR-AB1 cells, whereas the other BWZ.36 transfectants were unreactive to Ig or other stimuli (Fig. 1a) . To further investigate the specific binding of BWZ.36-CHIR-AB1 to IgY, we used IgY from yolk and serum either directly bound or immobilized via a mouse anti-chicken IgY mAb. In all cases a strong reaction was observed (Fig. 1b) . We next generated a mAb specific for CHIR-AB1, designated 8D12. This mAb also stimulated the CHIR-AB1 cells when it was immobilized to the plate. Moreover, the addition of soluble 8D12 was able to completely block the binding of IgY to CHIR-AB1 cells (Fig. 1b) . Additionally, mouse IgG1, IgG2a, IgG2b, IgG3, IgE, and IgA have been tested in the reporter assay, but they were all negative for CHIR-AB1 binding (data not shown).
A fusion protein with the single CHIR-AB1 Ig domain fused to the human C H 2, C H 3 Ig domains was generated to further test its specificity in an ELISA system. The soluble CHIR-AB1 construct bound IgY in a dose-dependent manner (Fig. 1c) . It also reacted with the Fc portion of IgY, but did not show any binding to the Fab fragment ( Fig. 1c) , thus clearly indicating that CHIR-AB1 is an Fc receptor specifically binding FcY. Because it has been shown that the FcY preparation only consists of the C H 3 and C H 4 domain the binding is limited to these domains (8) .
The binding of IgY to CHIR-AB1 was further tested on the stably transfected chicken B cell line 2D8. Surface expression of CHIR-AB1 could be detected by using the 8D12 mAb (data not shown). The 2D8-CHIR-AB1 cells strongly bound IgY, whereas untransfected 2D8 cells did not, indicating that CHIR-AB1 reacts with IgY. This binding could be blocked by preincubation with the mAb 8D12 (Fig. 1d ).
CHIR-AB1 Binds FcY with Nanomolar Affinity. We next investigated the CHIR-AB1-IgY interaction using surface plasmon resonance on a Biacore 2000 instrument (Biacore AB GE Healthcare, Uppsala, Sweden). Therefore CHIR-AB1 was covalently coupled onto a CM5 sensor chip and chicken serum IgY, chicken serum FcY, duck IgY, and mouse IgG were injected to immobilized CHIR-AB1 (Fig. 2a) . Whereas IgY and FcY yielded binding signals of 30 resonance units (RU) and 25 RU, respectively, duck IgY and mouse IgG showed no significant binding to CHIR-AB1. As a negative control we used CHIR-AB2 previously shown not to bind IgY, coupled to a reference surface. No binding signal was observed when injecting the Igs mentioned above.
To obtain detailed kinetic data for the interaction of FcY and IgY with CHIR-AB1, varying concentrations of analyte (412 pM to 100 nM FcY and 3.7-900 nM IgY) were injected to immobilized CHIR-AB1 ( Fig. 2 b and Cellular Expression Pattern of CHIR-AB1. The mAb 8D12 was used to determine the cellular expression pattern of CHIR-AB1 on different cellular subsets. Given the high number of CHIR genes, 8D12 may cross-react with other CHIR; however, we showed that 8D12 selectively stained BWZ.36 CHIR-AB1 cells, but not BWZ.36 CHIR-AB2 cells sharing 87% amino acid identity in its Ig domain [see supporting information (SI) Fig. 6 ]. As depicted in Fig. 3a , CHIR-AB1 was expressed by virtually all bursal B cells, but it was absent from thymocytes. Likewise, CHIR-AB1 ϩ cells in peripheral blood lymphocytes (PBL), spleen, and caecal tonsils were identified as Ig ϩ B cells by double staining, whereas no reactivity with 8D12 was found with CD3 ϩ T cells (Fig. 3a) . CHIR-AB1 was also detected on an intraepithelial intestinal lymphocyte population characterized by the expression of the 28-4 marker that identifies intestinal NK cells (18) (Fig. 3b) .
Various chicken cell lines were screened for 8D12 reactivity, but only the macrophage-derived cell lines LSCC-HD11 and BM2 were CHIR-AB1 positive (data not shown). When freshly isolated peripheral blood mononuclear cells (PBMC) were analyzed with the 8D12 mAb nearly all chicken monocytes defined by the specific marker KUL01 (19) were CHIR-AB1 ϩ (Fig. 3c) . The expression levels of some Fc receptors can be modified by inflammatory signals or cytokines. Therefore, macrophages prepared from PBMC were cultured for 3 days and successively activated with either LPS or IFN-␥. Although both reagents clearly stimulated the cells as judged by nitric oxide production (data not shown), the expression levels of CHIR-AB1 remained unaffected (Fig. 3d) . After comparing the cellular expression pattern of CHIR-AB1 with that obtained by RT-PCR earlier (15) differences appeared. We repeated the RT-PCR with 35 cycles instead of 30 cycles on the same tissues and were able to confirm the data obtained by mAb 8D12 (see SI Fig. 7 ). In conclusion, CHIR-AB1 is expressed on immature and mature B cells, and cells of the innate immune system such as NK cells, monocytes, and macrophages.
CHIR-AB1 Cross-Linking Induces FcRI␥-Dependent Calcium Influx.
The surface expression of activating mammalian Fc␥ receptors depends on the association with FcRI␥. In initial experiments performed in HEK 293T cells we found that CHIR-AB1 was expressed by itself on the cell surface and that the addition of chicken FcRI␥ did not enhance surface expression (data not shown). The sequence features of CHIR-AB1 suggest a potential activating function by association of the basic transmembrane residue with FcRI␥ and successive immunoreceptor tyrosinebased activation motif-mediated signaling. We have previously demonstrated that CHIR-A2, which has a nearly identical transmembrane region, depends on the FcRI␥ molecule for surface expression, arguing for a potential association of CHIR-AB1 with FcRI␥ (15) . Alternatively, the presence of a single cytoplasmic ITIM in CHIR-AB1 could be responsible for inhibitory activity of the receptor upon ligand binding. To further elucidate the function of CHIR-AB1, we generated single CHIR-AB1 transfectants and double CHIR-AB1/FcRI␥ transfectants in the chicken DT40 B cell line. In DT40 cells calcium flux can be triggered by cross-linking surface Ig with an anti-chicken IgM mAb (Fig. 4) . Stimulation of single CHIR-AB1 transfectants by either 8D12 mAb cross-linked via anti-mouse Ig or heat-aggregated IgY did not induce measurable calcium release (Fig. 4) . However, in the double CHIR-AB1/ FcRI␥ transfectants, a calcium flux similar to that after BCR ligation was observed after stimulation with the 8D12 mAb crosslinked via anti-mouse Ig or with heat-aggregated chicken IgY (Fig.  4) , whereas monomeric IgY did not induce calcium influx (data not shown).
Because FcRI␥ seems essential for activation of the calcium flux, we next tested which of the CHIR-AB1 ϩ cell populations are FcRI␥-positive by using real-time RT-PCR. The normalized re- sults reveal that PBMC, spleen, and PBMC-derived macrophages express FcRI␥ RNA, whereas the other tissues tested, including bursa, caecal tonsils, and PBL, were negative (Fig. 5) . These results indicate that cross-linking of CHIR-AB1 and activation of calcium signaling is limited to monocytes and macrophages where FcRI␥ is expressed.
Discussion
Here, we report the characterization of a nonmammalian Fc␥R that has several remarkable features. Initially, the CHIR genes have been isolated by using homology searches with mouse PIR-B probes in the chicken EST database (20) . Reciprocally mouse PIR-B itself was cloned in an attempt to find a homologue of the human Fc␣RI (CD89) (21) . This detour finally led to the identification of a chicken Fc receptor, CHIR-AB1, the best homologs of which are human KIR genes and mouse PIR genes.
CHIR-AB1 is a member of the chicken LRC representing a chromosomal region that contains Ͼ60 functional genes (14) . To further characterize their functions it was necessary to detect CHIR ligands. Given the exceedingly high number of CHIR genes, all available sequences were grouped based on sequence comparisons of their extracellular domains, and representative receptors were selected for ligand binding assays.
By this strategy IgY was found to strongly bind to CHIR-AB1, whereas ligands for other CHIR subgroups remain unknown. BLAST searches with the CHIR-AB1 Ig domain revealed Ϸ14 EST clones with high similarity (Ͼ80%) to CHIR-AB1. In addition, Laun et al. (14) showed that there are at least 10 different genes similar to CHIR-AB1 with Ͼ80% amino acid identity. We therefore predict that some of them will also bind to IgY, possibly showing a wide range of affinities. The different Fc receptors in mammals show restricted subclass specificity. IgY subclasses have not been reported, and the Ig genomic locus sequence is not available for an accurate investigation. Future work will thus be essential to identify all CHIR that are capable to bind Ig, measure their affinity, and determine chicken Ig complexity regarding subclasses.
One of the primordial aspects of CHIR-AB1 is that, unlike most Fc receptors, it consists of a single Ig domain, like the mammalian Fc␣/R (22) . The simpler CHIR-AB1 may represent therefore what was the primitive receptor that was recruited initially into the Fc receptor function during evolution of vertebrates. Duplicates of such single-Ig domain genes must have been supplemented by exon shuffling with extra domains that modified the binding affinities and therefore specificities of the receptor. The fact that the chicken has fewer isotypes of Ig than many vertebrates could imply that compared with mammals the number of Fc receptor might not have been under strong pressure to diversify, hence the possibility to find the chicken CHIR-AB1 still close to the ancestral form. Given the very large number of CHIR-related members it would imply that many do not function as Fc receptor. Under any circumstances the CHIR family is split into subfamilies with different functions. The coevolutionary aspects of the relationships Ig/Fc receptor will be another subject for comparative studies where the chicken peculiarities might be useful to pinpoint the essential from the accessory in the evolution of these families. This is even truer now that data in birds can be compared with cold-blooded vertebrates where new Ig isotypes and many families of Fc receptor-like genes have been discovered, and several new Ig isotypes have been discovered in fish and amphibians (23) .
The human Fc␥ receptor genes are clustered on chromosome 1. In an attempt to find a syntenic region in the chicken, we screened the current release (May 2006) of the chicken genome assembly (24) and identified only a single Fc receptor-like gene, which remains to be further analyzed. It is located on chicken chromosome 25 and is flanked by Ϸ20 unrelated genes that are also present in the human Fc receptor region on chromosome 1. This single Fc receptor-like gene was also identified by Taylor et al. (9) , but no Ig binding or other functional data could be obtained by this study. Although the gene assembly is far from being complete, this single gene leaves the interesting possibility that the majority of chicken Fc receptors are not encoded in the syntenic region of human chromosome 1, but instead may be encoded by various CHIR in the LRC. Moreover, in primates, horses, cows, and rats, the Fc␣RI genes (CD89) have been located in the LRC (25) and in cows, an additional Fc receptor designated bovine Fc␥2R is also found in the LRC (26) .
Most remarkably, CHIR-AB1 combines many features that are found on various mammalian Fc receptors. Its high affinity for IgY is reflected by the Fc␥RI (CD64) that shows also a nanomolar affinity (27) . Like Fc␥RI, CHIR-AB1 can bind to monomeric IgY, but for Ca 2ϩ mobilization it has to be cross-linked with heat- (Fig. 2a) . One of three representative experiments is shown.
Fig. 5.
FcRI␥ mRNA expression in different tissues. The FcRI␥ mRNA expression in the tissues indicated was evaluated by real-time RT-PCR. Ct values were normalized on 18S RNA and calibrated on liver by using the 2 Ϫ⌬⌬Ct formula. FcRI␥ mRNA was highly detectable in macrophages, PBMC, and spleen, whereas no or little transcript was detectable in the other tissues, including the CHIR-AB1-expressing bursa, PBL, and caecal tonsils.
aggregated IgY. The surface expression of most activating human Fc␥ receptors strictly depends on the association with FcRI␥. Although CHIR-AB1 can be expressed on the cell surface in the absence of FcRI␥, the triggering of intracellular Ca 2ϩ release depends on the adapter molecule, a situation similar to Fc␣RI.
Apart from similarities suggested by the chromosomal location and the independence on FcRI␥ for surface expression, Fc␣RI and CHIR-AB1 may also share the mode of binding to their ligands. In contrast to the Fc␥ receptors that bind the Ig via its lower hinge region at the N-terminal end of the C␥2 domain, IgA is bound in the C␣2 and C␣3 interdomain region (12) . The FcY preparation used in the assays only consists of the C3 and C4 domain, so the binding site for CHIR-AB1 must be located within those two most C-terminal-located regions (8) . Moreover, a conserved common binding site (28) found on all mammalian Fc␥ receptors is absent from CHIR-AB1, again arguing in favor of a distinct binding mode. Comparisons of all CHIR sequences used in the BWZ reporter gene assay point to a few apical regions unique to CHIR-AB1, especially in the FG loop, as a possible site for interactions with the Fc region (see SI Fig. 8 ). Future experiments with CHIR-AB1 should provide the exact binding site and the stoichiometry.
In mammals, activating Fc receptors are found on dendritic cells and innate immune cells such as granulocytes, monocytes, macrophages, mast cells, and NK cells. CHIR-AB1 is also expressed by some of these cells, although its presence on mast cells, dendritic cells, and granulocytes has not been evaluated because of difficulties in defining these cell populations in the chicken. Activating Fc receptors can be further modulated by inflammatory cytokines that increase their expression and by T helper 2 cytokines that decrease their expression. Neither IFN-␥ nor LPS treatment significantly changed the CHIR-AB1 expression levels; however, other cytokines need to be used in the future to test whether CHIR-AB1 can be up-or down-regulated. In addition, the regulation of CHIR-AB1 function may depend on the control of the FcRI␥ expression, because this adapter is essential for the activating function.
Unexpectedly for activating Fc receptors, CHIR-AB1 is also found on immature and mature B cells. This expression pattern is most similar to the inhibitory human Fc␥RIIB (3). It is possible that CHIR-AB1 mediates different signals in B cells as compared with the innate effector cells. The real-time RT-PCR results revealed that high FcRI␥ mRNA levels were present only in tissues containing innate immune cells such as macrophages, whereas mRNA was low or undetectable in PBL, bursa, and caecal tonsils, containing many immature/mature B cells. In addition to the transmembrane-positive charge that mediates the association with FcRI␥, the cytoplasmic tail of CHIR-AB1 contains at least two additional potential signaling motifs, a single ITIM, and in the place of the second ITIM, an YXXM motif, that may have been the result of an ITIM mutation. In the absence of FcRI␥, these cytoplasmic motifs could play an important role. Interestingly, Ca 2ϩ mobilization could not be inhibited by cocross-linking the BCR with CHIR-AB1 in single transfected DT40 CHIR-AB1 (data not shown). Either the assay itself is not suitable to detect the inhibitory potential of CHIR-AB1 or CHIR-AB1-encoded cytoplasmic motifs contribute to a different signaling capability. The human KIR2DL4 is the only Ig domain receptor described so far that displays a positive transmembrane charge in combination with a cytoplasmic ITIM. KIR2DL4 that is expressed only on NK cells seems to have primarily an activating function, whereas the role of the single cytoplasmic ITIM is still not resolved (29) .
In conclusion, CHIR-AB1 represents a unique high-affinity Fc receptor. As part of the huge multigene chicken LRC family, it may be only one representative of an entire Fc receptor family on microchromosome 31. Its FcRI␥-dependent activating function, various potential signaling capabilities, and expression by cells involved in innate immunity and B cells underscore its functional role and signaling plasticity.
Materials and Methods
Animals, Cell Preparation. Chicken line M11 (provided by S. Weigend, Federal Agricultural Research Center, Mariensee, Germany) was hatched at the Institute for Animal Physiology, University of Munich and used for experiments at the age of 3-10 weeks. For cell staining, lymphocytes from bursa, thymus, spleen, and ceacal tonsils were prepared by density centrifugation on FicollPaque (Amersham, Piscataway, NJ). For RNA preparation, 100 mg of bursa, thymus, spleen, ceacal tonsil, duodenum, bone marrow, liver, or brain was taken and directly frozen in liquid N 2 .
PBL were prepared by slow-speed centrifugation (30) , and intestinal intraepithelial lymphocytes were prepared as described (31) . Macrophage preparation from PBMC were performed as described (32) and stimulated for 24 h with either 1 g/ml LPS (Sigma, St. Louis, MO) or 10 ng/ml recombinant chicken IFN-␥ (33).
Cloning, Cell Lines, and Transfections. Reportergene constructs were cloned for CHIR subgroup members CHIR-A2 (GenBank accession no. AJ745093), CHIR-B2 (GenBank accession no. AJ639837), CHIR-B3 (GenBank accession no. AJ639838), CHIR-AB1 (GenBank accession no. AJ745094), CHIR-AB2 (GenBank accession no. AJ745095), or CHIR-AB3 (GenBank accession no. AJ879909). All of them were cloned as full-length constructs containing the MHC class I-derived signal peptide and an N-terminal FLAG epitope in a pcDNA3.1/V5-His expression vector (Invitrogen, Carlsbad, CA) as described (16) . The FLAG-tagged extracytoplasmic Ig domains were fused to the transmembrane domain of chicken CD8␣ (GenBank accession no. Z22726) and the cytoplasmic domain of murine CD3 (GenBank accession no. J04967) by linking PCR. The transmembrane domain of CD8␣ was introduced to ensure dimerization on the cell surface. The resulting constructs, all in pcDNA3.1/V5-His expression vectors (Invitrogen), were transfected into BWZ.36 cells (17) (25 g of plasmid for 3 ϫ 10 6 cells) by electroporation at 200 V with 950-F capacitance. Cells were selected in medium (RPMI medium 1640, 10% FCS) with 800 g/ml g418 (Applichem, Darmstadt, Germany), and single clones were screened for expression by anti-FLAG staining.
The chicken B cell line 2D8 (34) was transfected with the full-length FLAG-tagged CHIR-AB1 construct by using Metafectene Pro (Biontex, Martinsried, Germany) and selected as mentioned above.
For the soluble CHIR-AB1 construct (GenBank accession no. AM700586) the extracytoplasmic Ig domain of CHIR-AB1 was ligated to the hinge region, C H 2 and C H 3 domain of human IgG1 in the pcDNA3.1/V5-His expression vector (Invitrogen). HEK 293T cells were transfected by using the Metafectene reagent (Biontex), supernatants were harvested at 48 h posttransfection. Soluble dimerized CHIR-AB1 was affinity-purified on protein G-coupled Sepharose by using standard procedures.
For the Ca 2ϩ mobilization assay in DT40 cells the full-length FLAG-tagged CHIR-AB1 construct and the full-length V5-tagged FcRI␥ were used. The latter was constructed by inserting an N-terminal V5 epitope in the previously cloned FcRI␥ (GenBank accession no. AM700585) by linking PCR ligated into the XhoI site of pcDNA3.1/ZEO minus (Invitrogen). A total of 1 ϫ 10 7 DT40 cells were then electroporated with 20 g of linearized FLAG-CHIR-AB1 plasmid at 250 V with 950-F capacitance. Cells were selected with 1.5 mg/ml g418 (Applichem) and screened by cell staining with anti-FLAG, and a highly expressing clone was electroporated with V5-tagged FcRI␥ and selected with 250 g/ml zeocin (Invitrogen). All primers used for cloning are listed in SI Table 1 .
Igs, Antibodies, and Cell Staining. Chicken serum IgY either unlabeled or biotinylated, Fc fragment, and Fab fragment were purchased from Jackson ImmunoResearch Laboratories (West Grove,
